#RemeOs
March 22, 2024 at 10:34 AM
Bioretec on vaikeuksien jälkeen saanut biohajoavasta RemeOs™-traumaruuvistaan ensimmäisiä konkreettisia kasvun merkkejä. Toisaalta pääoman menettämisen riski osakkeessa on korkea kaupallisten epävarmuuksien ja rahoituksen riittävyyden vuoksi, jos yhtiö jää kasvutavoitteistaan.
June 25, 2026 at 5:13 AM
Bioretec Announces Change Negotiations to Improve Operational Efficiency and Competitiveness#Bioretec#Finland#Tampere#RemeOs#Activa
Bioretec Announces Change Negotiations to Improve Operational Efficiency and Competitiveness
Bioretec Ltd is set to commence negotiations focused on streamlining operations to boost efficiency and profitability, affecting its production team in Finland.
third-news.com
June 1, 2026 at 5:07 PM
Bioretec Ltd Launches Innovative Stock Option Plan to Boost Employee Commitment and Shareholder Value#Bioretec#Finland#Tampere#RemeOs#Activa
Bioretec Ltd Launches Innovative Stock Option Plan to Boost Employee Commitment and Shareholder Value
Bioretec Ltd's Board has approved a new stock option plan aimed at incentivizing key personnel. This initiative seeks to enhance long-term shareholder value and employee commitment.
third-news.com
June 1, 2026 at 4:44 PM
Bioretec Ltd's Q1 2026 Review: Progress from New Strategic Initiatives#Bioretec#Finland#Tampere#financial_report#RemeOs
Bioretec Ltd's Q1 2026 Review: Progress from New Strategic Initiatives
Bioretec Ltd's Q1 2026 review highlights early successes from strategic realignments, showcasing increased net sales and operational efficiency.
third-news.com
May 15, 2026 at 7:17 AM
Bioretec Ltd. Reports Early Progress with New Strategy in Q1 2026 Business Review#Bioretec#Finland#Tampere#RemeOs#Ltd.
Bioretec Ltd. Reports Early Progress with New Strategy in Q1 2026 Business Review
Bioretec Ltd. unveils its quarter one 2026 business review, highlighting early success from its renewed strategy and operational improvements in key markets.
third-news.com
May 15, 2026 at 7:06 AM
Bioretec Reveals Revised Financial Goals for 2026-2028 with New Sales Margin Reporting#Bioretec#Finland#Helsinki#RemeOs#Activa
Bioretec Reveals Revised Financial Goals for 2026-2028 with New Sales Margin Reporting
Bioretec has announced changes to its financial goals for 2026-2028, emphasizing an adjusted sales margin to align with industry standards, enhancing transparency.
third-news.com
May 13, 2026 at 8:35 PM
Bioretec Ltd's Board of Directors Makes Key Appointments at Constitutive Meeting#Bioretec#Finland#Helsinki#RemeOs#Kustaa_Poutiainen
Bioretec Ltd's Board of Directors Makes Key Appointments at Constitutive Meeting
Bioretec Ltd recently held a constitutive meeting of its Board of Directors, making important appointments and confirming member independence.
third-news.com
May 8, 2026 at 6:13 PM
Bioretec Ltd Unveils Resolutions from 2026 Annual General Meeting: Key Decisions and Future Directions#Bioretec#RemeOs#Activa
Bioretec Ltd Unveils Resolutions from 2026 Annual General Meeting: Key Decisions and Future Directions
The 2026 Annual General Meeting of Bioretec Ltd outlines major decisions including board re-elections, financial resolutions, and future auditing plans.
third-news.com
May 8, 2026 at 12:25 PM
Bioretec Ltd Registers Important Shareholding Notification Under Finnish Securities Act#Bioretec#Finland#Helsinki#RemeOs#Sp-Rahastoyhtiö
Bioretec Ltd Registers Important Shareholding Notification Under Finnish Securities Act
Bioretec Ltd has officially notified the market about a significant increase in shareholding by Sp-Rahastoyhtiö Oy, surpassing 5%.
third-news.com
April 29, 2026 at 3:28 PM
Bioretec Ltd Successfully Registers New Shares Following Rights Issue Completion#Bioretec#Finland#Helsinki#RemeOs#Activa
Bioretec Ltd Successfully Registers New Shares Following Rights Issue Completion
Bioretec Ltd has successfully completed its rights issue, resulting in the registration of over 1.2 billion new shares, boosting its market presence and investor engagement.
third-news.com
April 28, 2026 at 12:01 PM
Bioretec Ltd Updates Stock Option Program Following Successful Rights Issue Completion#Bioretec#Finland#Helsinki#RemeOs#Activa
Bioretec Ltd Updates Stock Option Program Following Successful Rights Issue Completion
Bioretec Ltd has finalized its rights issue and made adjustments to its stock option terms, ensuring fairness to all investors involved.
third-news.com
April 28, 2026 at 11:32 AM
Bioretec Ltd Announces Key Managerial Transactions by CFO Tuukka Paavola#Bioretec#Finland#Tampere#RemeOs#Tuukka_Paavola
Bioretec Ltd Announces Key Managerial Transactions by CFO Tuukka Paavola
Bioretec Oy's CFO, Tuukka Paavola, has made significant transactions involving share subscriptions on April 24, 2026. Discover the details.
third-news.com
April 27, 2026 at 2:25 PM
Bioretec Ltd's Rights Issue: Preliminary Results and Insights into Future Growth Opportunities#Bioretec#Finland#Tampere#RemeOs#Stephen_Industries
Bioretec Ltd's Rights Issue: Preliminary Results and Insights into Future Growth Opportunities
Bioretec Ltd announces preliminary results from its recent rights issue, highlighting robust shareholder participation and plans for future growth in the orthopedic device sector.
third-news.com
April 23, 2026 at 2:34 PM
Bioretec Ltd Reports Significant Management Transactions in the Medical Device Sector#Bioretec#Finland#Medical_Devices#Helsinki#RemeOs
Bioretec Ltd Reports Significant Management Transactions in the Medical Device Sector
Bioretec Oy recently announced important management transactions, highlighting their growth in developing cutting-edge orthopedic implants in the medical sector.
third-news.com
April 15, 2026 at 10:23 AM
Bioretec Oy's Latest Managerial Transactions and Innovations in Orthopedic Care#Bioretec#Finland#Helsinki#RemeOs#Kustaa_Poutiainen
Bioretec Oy's Latest Managerial Transactions and Innovations in Orthopedic Care
Explore the latest managerial transactions from Bioretec Oy and their innovative advancements in biodegradable orthopedic implants, enhancing patient care.
third-news.com
April 15, 2026 at 10:10 AM
Bioretec Ltd Unveils Rights Issue Exemption Document for Shareholders#Bioretec#Finland#Helsinki#RemeOs#Activa
Bioretec Ltd Unveils Rights Issue Exemption Document for Shareholders
Bioretec Ltd introduces an exemption document for its upcoming rights issue, offering shareholders a chance to acquire new shares at an attractive price.
third-news.com
April 2, 2026 at 3:34 PM
Bioretec Ltd Launches Rights Issue with Comprehensive Exemption Document for Shareholders#Bioretec#Finland#Helsinki#RemeOs#Activa
Bioretec Ltd Launches Rights Issue with Comprehensive Exemption Document for Shareholders
Bioretec Ltd has initiated a rights issue, offering up to 1.4 billion new shares, detailed in a newly published exemption document to existing shareholders.
third-news.com
April 2, 2026 at 2:43 PM